+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Moderate and Severe Chronic Kidney Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate and Severe Chronic Kidney Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Peptide Therapeutics Market 2024-2028 - Product Thumbnail Image

Peptide Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 148 Pages
  • Global
From
Protein Therapeutics Market 2024-2028 - Product Thumbnail Image

Protein Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 191 Pages
  • Global
From
Lyophilized Injectable Drugs Market Report 2025 - Product Thumbnail Image

Lyophilized Injectable Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Biomarkers Market Report 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Biomarkers Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Bio-pharma Market 2024-2028 - Product Thumbnail Image

Bio-pharma Market 2024-2028

  • Report
  • December 2023
  • 184 Pages
  • Global
From
From
From
From
From
From
Women Health Therapeutics Market 2024-2028 - Product Thumbnail Image

Women Health Therapeutics Market 2024-2028

  • Report
  • November 2024
  • 180 Pages
  • Global
From
From
Loading Indicator